September 12, 2025

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Potential 45.94% Upside in the Biotech Sector

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline and strategic market positioning. With its focus on developing novel..

SI-BONE, Inc. (SIBN) Stock Analysis: Robust Revenue Growth and Significant Upside Potential for Investors

SI-BONE, Inc. (NASDAQ: SIBN), a notable player in the healthcare sector specializing in medical devices, is attracting significant investor interest. Based in Santa Clara, California, SI-BONE focuses on innovative solutions..

RxSight, Inc. (RXST) Stock Report: Navigating the Medical Device Market with a Unique Edge

RxSight, Inc. (RXST), a company at the forefront of the medical device industry, is making headlines with its innovative approach to cataract surgery. RXST, traded on the U.S. exchanges, specializes..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: Significant 129% Potential Upside with Innovative Cancer Treatments

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a promising player in the biotechnology sector, has captured the attention of investors with its impressive portfolio of cancer therapies and a remarkable potential upside..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a Promising 111% Potential Upside

Investors watching the biopharmaceutical sector may want to take a closer look at Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage company that has been capturing attention with its innovative approach..

AMN Healthcare Services Inc (AMN): Investor Outlook with a 5.49% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the U.S. healthcare staffing industry, presents a mixed bag of opportunities and challenges for investors. With its current market capitalization..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a 24.66% Potential Upside in Biotech

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is capturing investor attention in the biotechnology sector, thanks to its promising pipeline and significant potential upside. As a biopharmaceutical company headquartered in Solana Beach,..

Beta Bionics, Inc. (BBNX) Stock Analysis: Navigating the Ups and Downs with a 52-Week High

Beta Bionics, Inc. (NASDAQ: BBNX), a trailblazer in the healthcare sector, is making waves in the medical devices industry with its innovative solutions targeting diabetes management. At the heart of..

HealthStream, Inc. (HSTM) Stock Analysis: Navigating a 16.36% Potential Upside in the Healthcare SaaS Arena

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services industry, is catching the eye of investors keen on capitalizing on the technological evolution within healthcare. With a..

OrthoPediatrics Corp. (KIDS) Investor Outlook: A 66.54% Potential Upside in Pediatric Orthopedic Innovation

OrthoPediatrics Corp. (NASDAQ: KIDS), a specialized medical device company headquartered in Warsaw, Indiana, is making waves in the healthcare sector, particularly within the niche market of pediatric orthopedics. With a..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 205.95% Upside Potential in Cancer Treatment Innovations

Kura Oncology, Inc. (NASDAQ: KURA) is gaining the attention of investors with its promising pipeline in the biotechnology sector, particularly in the niche of cancer therapeutics. Based in San Diego,..

Xencor, Inc. (XNCR) Investor Outlook: Exploring a Potential 183.53% Upside in Biotech

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company based in Pasadena, California, has recently captured investor attention with a potential upside of 183.53%, according to analyst ratings and targets. Specializing..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Uncovering a 102% Potential Upside for Investors

AbCellera Biologics Inc. (NASDAQ: ABCL), a trailblazing Canadian biotech company, is making significant strides in the healthcare sector with its cutting-edge antibody-based medicines. As the company continues to make advancements..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Biotechnology Innovator with 64% Potential Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), headquartered in Waltham, Massachusetts, is capturing investor attention with its strategic focus on precision therapies for genetically defined diseases. As a key player in the..

Arcus Biosciences, Inc. (RCUS) Investor Outlook: A Biotech with 146.64% Upside Potential

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is emerging as a compelling opportunity in the biotechnology sector. With an impressive potential upside of 146.64%, as indicated by the..

Replimune Group, Inc. (REPL)

⚠️ No article content returned.

..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A Promising Biotech with 60% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology firm based in New York, is making waves in the healthcare sector with its innovative approach to tackling severe autoimmune and inflammatory..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: A Biotech Gem with a 47.85% Upside Potential

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a noteworthy player in the healthcare sector, particularly within the biotechnology industry. Headquartered in San Diego, California, the company operates in two main..

Arbutus Biopharma Corporation (ABUS) Investor Outlook: Exploring a 522% Revenue Growth in the Biotech Arena

Arbutus Biopharma Corporation (NASDAQ: ABUS) has been a focal point in the biotechnology sector, capturing the attention of investors with its remarkable revenue growth and strategic advancements in the field..

Avadel Pharmaceuticals plc (AVDL) Investor Outlook: Exploring a 27% Potential Upside with Strong Buy Ratings

Avadel Pharmaceuticals plc (NASDAQ: AVDL) has been attracting attention in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Avadel is making strides..

Search

Funds

September 12, 2025

Search

Funds

September 12, 2025

FTSE 100

Funds